Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study.

Schmalzing MarcHerbert KellnerAyman AskariJavier De Toro SantosJulio Cesar Vazquez Perez-ColemanRosario FotiSławomir JekaBoulos HaraouiYannick AllanorePeter PeichlMartin OehriMasiur RahmanFabricio FurlanElisa RomeroSohaib HachaichiCharlotte BothInes BrueckmannTom Sheeran

Published in: Advances in therapy (2023)

These results support the effectiveness and safety of SDZ ETN treatment in patients with RA, axSpA or PsA in real-life conditions. The treatment persistence rates observed were consistent with previously published reports of patients treated with reference or other biosimilar ETN. No new safety signals were identified.

Keyphrases

rheumatoid arthritis
prostate cancer
systematic review
emergency department
ankylosing spondylitis
combination therapy
replacement therapy
radical prostatectomy